Author:
Opoku-Agyemang Frank,Naa Offeibea Dodoo Jessica,Elorm Hlomador Theophilus,Gilday Kathleen,Naalamle Amissah Jacqueline
Abstract
Cryptolepis sanguinolenta (Cs) is a medicinal plant, indigenous to the West Africa sub-region and has been utilized in Ghana to treat malaria for generations. Besides being used as an antimalarial treatment in Ghana, Cs has been noted as being used in the US to treat Babesia, Lyme disease (Borreliosis burgdorferi), Bartonella, among others. The plant contains several indoloquinoline alkaloids, mainly concentrated in its root system, giving the plant its antimicrobial, antihyperglycemic, and anticancer properties. However, the destructive harvesting of the entire plant, along with its root system, is not sustainable over the long term and has already resulted in a substantial decrease in wild populations, threatening its long-term potential and survivability. This book chapter will discuss its uses, conservation strategies and cultivation protocols developed for Cs to ensure a reliable supply of plant material as well as its sustainable utilization.
Reference66 articles.
1. McGuffin M, Kartesz JT, Leung AY, Tucker AO. Herbs of Commerce. 2nd. American Herbal Products Association. Silver Spring. 2000. 442p
2. Osafo N, Mensah KB, Yeboah OK. Phytochemical and pharmacological review of Cryptolepis sanguinolenta (Lindl.) Schlechter. Advances in Pharmacological Sciences. 2017;2017:1-13
3. Jansen PCM, Schmelzer GH. Cryptolepis sanguinolenta (Lindl.) Schltr. In: Schmelzer GH, Gurib-Fakim A, editors. Prota 11(2): Medicinal plants/ Plantes médicinales 2. [CD-Rom]. PROTA, Wageningen, Netherlands. PRO. 2010;11
4. Ameyaw Y. Morpho-histological characters for the identification of Cryptolepis sanguinolenta (Lindl.) Schtr. International Journal of Science and Nature. 2012;3:331-339
5. Addy M. Cryptolepis: An African traditional medicine that provides hope for malaria victims. HerbalGram. 2003;60:54-59
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献